nach oben

Erschienen in:

01.09.2023 | Original Paper

EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells

verfasst von: Rajalakshmi Sabanayagam, Sneha Krishnamoorthy, Jayapradha Gnanagurusamy, Bharathi Muruganatham, Sridhar Muthusami

Erschienen in: Medical Oncology | Ausgabe 9/2023

Einloggen, um Zugang zu erhalten

Abstract

Our previous laboratory findings suggested the beneficial effects of epigallocatechin gallate (EGCG) against cervical cancer (CC) cells survival. The present study is aimed at identifying the effects of EGCG in preventing the actions of epidermal growth factor (EGF) in human papilloma virus (HPV) 68 positive ME180 and HPV negative C33A CC cells. An elevated level of EGF in tumor micro-environment (TME) is linked to the metastasis of several cancers including CC. We hypothesized that EGCG has the ability to block the actions of EGF. To test this, survival assay was performed in cells treated with or without EGF and EGCG. The mitochondrial activity of cells was ascertained using MTT assay and mitored staining. Protein and non-protein components in the extracellular matrix such as collagen and sulphated glycosaminoglycans (GAGs) were evaluated using sirius red and alcian blue staining, respectively. Matrix metalloproteinase-2 (MMP-2) gene expression and enzymatic activity were assessed using real time-reverse transcriptase-polymerase chain reaction (RT-PCR) and gelatin zymography. Wound healing assay was performed to assess the EGF induced migratory ability and its inhibition by EGCG pre-treatment. Clonogenic assay showed that EGCG pre-treatment blocked the EGF driven colony formation. In silico analysis performed identified the efficacy of EGCG in binding with different domains of EGF receptor (EGFR). EGCG pre-treatment prevented the epithelial–mesenchymal transition (EMT) and metabolic activity induced by EGF, this is associated with concomitant reduction in the gene expression and enzyme activity of MMP-2. Further, reduced migration and ability to form colonies were observed in EGCG pre-treated cells when stimulated with EGF. HPV positive ME180 cells showed increased migratory and clonogenic ability upon EGF stimulation, whose effects were not much significant in HPV negative C33A cells. EGCG effectively blocked the actions of EGF in both HPV positive and HPV negative conditions and can be advocated as supplementary therapy for the management of EGF driven CC. However, further studies using cell line-derived xenograft (CDX)/patient-derived xenograft (PDX) model system is warranted to validate the therapeutic utility of EGCG.

Graphical abstract

Muthusami S, Sabanayagam R, Periyasamy L, Muruganantham B, Park WY. A review on the role of epidermal growth factor signaling in the development, progression and treatment of cervical cancer. Int J Biol Macromol. 2022;194:179–87. https://doi.org/10.1016/j.ijbiomac.2021.11.117.CrossRefPubMed

Hugo de Almeida V, Guimarães IDS, Almendra LR, Rondon AMR, Tilli TM, de Melo AC, Sternberg C, Monteiro RQ. Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer. Oncotarget. 2018;9(55):30594–609. https://doi.org/10.18632/oncotarget.25748.CrossRefPubMedPubMedCentral

Muthusami S, Prabakaran DS, Yu JR, Park WY. EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial–mesenchymal transition and promotes cell migration in ME180 cervical cancer cells. Cancer Lett. 2014;351(2):252–9. https://doi.org/10.1016/j.canlet.2014.06.007.CrossRefPubMed

Thomas R, Weihua Z. Rethink of EGFR in cancer with its kinase independent function on board. Front Oncol. 2019;9:800. https://doi.org/10.3389/fonc.2019.00800.CrossRefPubMedPubMedCentral

Cai WQ, Zeng LS, Wang LF, Wang YY, Cheng JT, Zhang Y, Han ZW, Zhou Y, Huang SL, Wang XW, Peng XC, Xiang Y, Ma Z, Cui SZ, Xin HW. The latest battles between EGFR monoclonal antibodies and resistant tumor cells. Front Oncol. 2020;10:1249. https://doi.org/10.3389/fonc.2020.01249.CrossRefPubMedPubMedCentral

Zou C, Liu H, Feugang JM, Hao Z, Chow HH, Garcia F. Green tea compound in chemoprevention of cervical cancer. Int J Gynecol Cancer. 2010;20(4):617–24. https://doi.org/10.1111/IGC.0b013e3181c7ca5c.CrossRefPubMedPubMedCentral

Butler LM, Wu AH. Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res. 2011;55(6):931–40. https://doi.org/10.1002/mnfr.201100058. (Epub 19 May 2011).CrossRefPubMedPubMedCentral

Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM. Human oncoviruses and p53 tumor suppressor pathway deregulation at the origin of human cancers. Cancers (Basel). 2018;10(7):213.CrossRefPubMed

Muthusami S, Prabakaran DS, An Z, Yu JR, Park WY. EGCG suppresses Fused Toes Homolog protein through p53 in cervical cancer cells. Mol Biol Rep. 2013;40(10):5587–96. https://doi.org/10.1007/s11033-013-2660-x.CrossRefPubMed

10.

Periyasamy L, Murugantham B, Sundararaj R, Krishnamoorthy S, Muthusami S. Screening of MMP-2 inhibiting phytoconstituents for the development of newer pancreatic cancer modalities. Protein Pept Lett. 2023;30(4):304–13. https://doi.org/10.2174/0929866530666230213113835.CrossRefPubMed

11.

Shoaib S, Islam N, Yusuf N. Phytocompounds from the medicinal and dietary plants: multi-target agents for cervical cancer prevention and therapy. Curr Med Chem. 2022;29(26):4481–506. https://doi.org/10.2174/0929867329666220301114251.CrossRefPubMed

12.

Kilic U, Sahin K, Tuzcu M, Basak N, Orhan C, Elibol-Can B, Kilic E, Sahin F, Kucuk O. Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Front Nutr. 2015;1:28. https://doi.org/10.3389/fnut.2014.00028.CrossRefPubMedPubMedCentral

13.

Panji M, Behmard V, Zare Z, Malekpour M, Nejadbiglari H, Yavari S, Nayerpour Dizaj T, Safaeian A, Maleki N, Abbasi M, Abazari O, Shabanzadeh M, Khanicheragh P. Suppressing effects of green tea extract and Epigallocatechin-3-gallate (EGCG) on TGF-β-induced epithelial-to-mesenchymal transition via ROS/Smad signaling in human cervical cancer cells. Gene. 2021;794:145774. https://doi.org/10.1016/j.gene.2021.145774.CrossRefPubMed

14.

Wang W, Xu B, Xuan H, Ge Y, Wang Y, Wang L, Huang J, Fu W, Michie SA, Dalman RL. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease. J Vasc Surg. 2018;68(5):1538–50.e2. https://doi.org/10.1016/j.jvs.2017.09.030.CrossRefPubMed

15.

Zhu Y, Huang Y, Liu M, Yan Q, Zhao W, Yang P, Gao Q, Wei J, Zhao W, Ma L. Epigallocatechin gallate inhibits cell growth and regulates miRNA expression in cervical carcinoma cell lines infected with different high-risk human papillomavirus subtypes. Exp Ther Med. 2019;17(3):1742–8. https://doi.org/10.3892/etm.2018.7131.CrossRefPubMed

16.

Fullár A, Dudás J, Oláh L, Hollósi P, Papp Z, Sobel G, Karászi K, Paku S, Baghy K, Kovalszky I. Remodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression. BMC Cancer. 2015;15:256. https://doi.org/10.1186/s12885-015-1272-3.CrossRefPubMedPubMedCentral

17.

Cruz L, Meyers C. Differential dependence on host cell glycosaminoglycans for infection of epithelial cells by high-risk HPV types. PLoS ONE. 2013;8(7):e68379. https://doi.org/10.1371/journal.pone.0068379.CrossRefPubMedPubMedCentral

18.

Liu S, Liao G, Li G. Regulatory effects of COL1A1 on apoptosis induced by radiation in cervical cancer cells. Cancer Cell Int. 2017;17:73. https://doi.org/10.1186/s12935-017-0443-5.CrossRefPubMedPubMedCentral

19.

Li Q, Wang Q, Zhang Q, Zhang J, Zhang J. Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer. Am J Transl Res. 2019;11(11):6938–51.PubMedPubMedCentral

20.

Chen W, Huang S, Shi K, Yi L, Liu Y, Liu W. Prognostic role of matrix metalloproteinases in cervical cancer: a meta-analysis. Cancer Control. 2021. https://doi.org/10.1177/10732748211033743.CrossRefPubMedPubMedCentral

21.

Mitra A, Chakrabarti J, Chattopadhyay N, Chatterjee A. Membrane-associated MMP-2 in human cervical cancer. J Environ Pathol Toxicol Oncol. 2003;22(2):93–100. https://doi.org/10.1615/jenvpathtoxoncol.v22.i2.20.CrossRefPubMed

22.

Muthusami S, Senthilkumar K, Vignesh C, Ilangovan R, Stanley J, Selvamurugan N, Srinivasan N. Effects of Cissus quadrangularis on the proliferation, differentiation and matrix mineralization of human osteoblast like SaOS-2 cells. J Cell Biochem. 2011;112(4):1035–45. https://doi.org/10.1002/jcb.23016.CrossRefPubMed

23.

Periyasamy L, Murugantham B, Muthusami S. Plumbagin binds to epidermal growth factor receptor and mitigate the effects of epidermal growth factor micro-environment in PANC-1 cells. Med Oncol. 2023;40(7):184. https://doi.org/10.1007/s12032-023-02048-z.CrossRefPubMed

24.

Krishnan A, Muthusami S, Periyasamy L, Stanley JA, Gopalakrishnan V, Ramachandran I. Effect of DHT-induced hyperandrogenism on the pro-inflammatory cytokines in a rat model of polycystic ovary morphology. Medicina (Kaunas). 2020;56(3):100. https://doi.org/10.3390/medicina56030100.CrossRefPubMed

25.

Periyasamy L, Muruganantham B, Deivasigamani M, Lakshmanan H, Muthusami S. Acetogenin extracted from Annona muricata prevented the actions of EGF in PA-1 ovarian cancer cells. Protein Pept Lett. 2021;28(3):304–14. https://doi.org/10.2174/0929866527666200916141730.CrossRefPubMed

26.

Sharma C, Qel-A N, Begum S, Javed E, Rizvi TA, Hussain A. (−)-Epigallocatechin-3-gallate induces apoptosis and inhibits invasion and migration of human cervical cancer cells. Asian Pac J Cancer Prev. 2012;13(9):4815–22. https://doi.org/10.7314/apjcp.2012.13.9.4815.CrossRefPubMed

27.

Wang L, Wei Y, Fang W, Lu C, Chen J, Cui G, Diao H. Cetuximab enhanced the cytotoxic activity of immune cells during treatment of colorectal cancer. Cell Physiol Biochem. 2017;44(3):1038–50. https://doi.org/10.1159/000485404.CrossRefPubMed

28.

Yuan Y, Cai X, Shen F, Ma F. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 2021;497:243–54. https://doi.org/10.1016/j.canlet.2020.10.034.CrossRefPubMed

29.

Herbster S, Paladino A, de Freitas S, Boccardo E. Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases. Clinics (Sao Paulo). 2018;73(Suppl 1):e551s. https://doi.org/10.6061/clinics/2018/e551s.CrossRefPubMed

30.

Thangavelu PU, Krenács T, Dray E, Duijf PH. In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion. Clin Epigenet. 2016;8:120. https://doi.org/10.1186/s13148-016-0290-6.CrossRef

31.

Yang N, Zhang H, Cai X, Shang Y. Epigallocatechin-3-gallate inhibits inflammation and epithelial–mesenchymal transition through the PI3K/AKT pathway via upregulation of PTEN in asthma. Int J Mol Med. 2017;41(2):818–28. https://doi.org/10.3892/ijmm.2017.3292.CrossRefPubMedPubMedCentral

32.

Sah JF, Balasubramanian S, Eckert RL, Rorke EA. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J Biol Chem. 2004;279(13):12755–62. https://doi.org/10.1074/jbc.M312333200.CrossRefPubMed

33.

Sizemore N, Rorke EA. Human papillomavirus 16 immortalization of normal human ectocervical epithelial cells alters retinoic acid regulation of cell growth and epidermal growth factor receptor expression. Cancer Res. 1993;53(19):4511–7.PubMed

34.

Masuda M, Suzui M, Yasumatu R, Nakashima T, Kuratomi Y, Azuma K, Tomita K, Komiyama S, Weinstein IB. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 2002;62(12):3351–5.PubMed

Titel: EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells
verfasst von: Rajalakshmi Sabanayagam
Sneha Krishnamoorthy
Jayapradha Gnanagurusamy
Bharathi Muruganatham
Sridhar Muthusami
Publikationsdatum: 01.09.2023
Verlag: Springer US
Erschienen in: Medical Oncology / Ausgabe 9/2023
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI: https://doi.org/10.1007/s12032-023-02135-1

Springer Medizin

EGCG attenuate EGF triggered matrix abundance and migration in HPV positive and HPV negative cervical cancer cells

Abstract

Graphical abstract

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie

Springer Medizin

Abstract

Graphical abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2023

Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming

Artichoke as a melanoma growth inhibitor

METTL3 regulatory TROAP can regulate the progression of non-small cell lung cancer through PI3K/AKT and EMT signaling pathway

The Schiff base hydrazine copper(II) complexes induce apoptosis by P53 overexpression and prevent cell migration through protease-independent pathways

Concomitant effects of paclitaxel and celecoxib on genes involved in apoptosis of triple-negative metastatic breast cancer cells

The mechanistic insights of the antioxidant Keap1-Nrf2 pathway in oncogenesis: a deadly scenario

Neu im Fachgebiet Onkologie

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

Alter verschlechtert Prognose bei Endometriumkarzinom

Darf man die Behandlung eines Neonazis ablehnen?

Update Onkologie